Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism.

Hussein WI, Green R, Jacobsen DW, Faiman C.

Ann Intern Med. 1999 Sep 7;131(5):348-51.

PMID:
10475887
2.

Homocysteine concentrations in subclinical hypothyroidism.

Sengül E, Cetinarslan B, Tarkun I, Cantürk Z, Türemen E.

Endocr Res. 2004 Aug;30(3):351-9.

PMID:
15554351
3.

Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism.

Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersinga WM.

Clin Endocrinol (Oxf). 2001 Feb;54(2):197-204.

PMID:
11207634
4.

Homocysteine, folate and cobalamin levels in hypothyroid women before and after treatment.

Orzechowska-Pawilojc A, Sworczak K, Lewczuk A, Babinska A.

Endocr J. 2007 Jun;54(3):471-6. Epub 2007 Apr 27.

5.

Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease.

Giannetti N, Herity NA, Alimollah A, Gao SZ, Schroeder JS, Yeung AC, Hunt SA, Valantine HA.

Clin Transplant. 2001 Aug;15(4):247-52.

PMID:
11683818
6.

Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus.

Soinio M, Marniemi J, Laakso M, Lehto S, Rönnemaa T.

Ann Intern Med. 2004 Jan 20;140(2):94-100.

PMID:
14734331
7.

Plasma total homocysteine levels in hyperthyroid and hypothyroid patients.

Nedrebø BG, Ericsson UB, Nygård O, Refsum H, Ueland PM, Aakvaag A, Aanderud S, Lien EA.

Metabolism. 1998 Jan;47(1):89-93.

PMID:
9440483
8.
9.

Hyperhomocysteinemia and retinal vascular occlusive disease.

Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS.

Eur J Ophthalmol. 2002 Nov-Dec;12(6):495-500.

PMID:
12510718
10.

Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.

Cakal E, Turgut AT, Demirbas B, Ozkaya M, Cakal B, Serter R, Aral Y.

Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):294-300. doi: 10.1055/s-0028-1085998. Epub 2008 Sep 30.

PMID:
19085705
11.

Is subclinical hypothyroidism associated with hyperhomocysteinemia?

Aldasouqi S, Nkansa-Dwamena D, Bokhari S, Alzahrani AS, Khan M, Al-Reffi A, Merdad A.

Endocr Pract. 2004 Sep-Oct;10(5):399-403.

PMID:
15760786
12.

Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy?

Gursoy A, Ozduman Cin M, Kamel N, Gullu S.

Int J Clin Pract. 2006 Jun;60(6):655-9.

PMID:
16805747
13.

Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.

Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J.

Ann Intern Med. 2005 Mar 15;142(6):412-24.

PMID:
15767619
14.

Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.

Unlü Y, Keleş S, Becit N, Koçoğullari CU, Koçak H, Bakan E.

Eur J Vasc Endovasc Surg. 2005 Sep;30(3):315-8.

15.

Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.

Zoccolella S, Simone IL, Lamberti P, Samarelli V, Tortelli R, Serlenga L, Logroscino G.

Neurology. 2008 Jan 15;70(3):222-5. doi: 10.1212/01.wnl.0000297193.53986.6f.

PMID:
18195267
16.

Oral challenge with a methionine load in patients with inflammatory bowel disease: a better test to identify hyperhomocysteinemia.

Zepeda-Gómez S, Montano-Loza A, Zapata-Colindres JC, Vargas-Vorackova F, Majluf-Cruz A, Uscanga L.

Inflamm Bowel Dis. 2008 Mar;14(3):383-8.

PMID:
17924554
17.
18.

A study of plasma total homocysteine levels in healthy people.

Angelova EA, Minkova GD, Atanasova PA, Semerdjieva MA, Tzvetkova TZ.

Folia Med (Plovdiv). 2005;47(3-4):53-8.

PMID:
16761395
19.
20.

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.

Taylor LM Jr, Moneta GL, Sexton GJ, Schuff RA, Porter JM.

J Vasc Surg. 1999 Jan;29(1):8-19; discussion 19-21.

Supplemental Content

Support Center